1887

Chapter 46 : Enteroviruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Enteroviruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch46-1.gif /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch46-2.gif

Abstract:

The genus (EV) was so designated because its members replicate primarily in the human gastrointestinal (GI) tract. The original taxonomic classification of the EVs recognized 64 prototype serotypes within the family (“pico” meaning small, “rna” for ribonucleic acid genome) (Table 1) (1, 2). Additional serotypes continue to be discovered, and the original genus currently has more than 100 confirmed serotypes (3, 4). The “traditional” species designation within the genus includes the polioviruses (PV), coxsackieviruses A and B (CV-A and CV-B, respectively), echoviruses (E), and the “numbered” EVs (Table 1). The original speciation of the EVs was based on the ability of individual serotypes to grow in various cell cultures and produce disease in animal systems (1).

Citation: Romero J. 2017. Enteroviruses, p 1113-1142. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch46
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Schematic representation of the icosahedral viral capsid structure of the enteroviruses, as represented by poliovirus. The five-fold (5x), three-fold (3x), and two-fold (2x) axes of symmetry are indicated. The position of one of the 60 repeating protomeric units, each comprised of the surface exposed proteins VP1, VP2, and VP3. . Computer model of poliovirus. The five-fold (5x), three-fold (3x), and two-fold (2x) axes of symmetry are indicated. The canyon is indicated by an arrow. Schematic representation of the poliovirus proteins. a) Diagram of the structurally conserved core of the 3 major capsid proteins (VP1-3) comprised by an eight-stranded, wedge shaped, antiparallel beta-barrel core. The ribbon diagrams of b) VP1, c) VP2, and d) VP3 are shown with the locations of the major neutralizing antigenic sites (N-Ags) of poliovirus type 1. (Reprinted from Jiang P, Liu Y, Ma HC, Paul AV, Wimmer E. 2014. Picornavirus morphogenesis. :418–437 with permission.)

Citation: Romero J. 2017. Enteroviruses, p 1113-1142. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Genome organization and translation products of the enteroviruses, as represented by poliovirus The poliovirus genome. 5′ NTR, 5′ nontranslated region. IRES, internal ribosome entry site. Numerals I–VI represent stem-loop structures within the 5′ NTR. 3′ NTR, 3′ nontranslated region. The poly-A tail at the 3′ end of the RNA is indicated by “AAAn-. . Proteins of poliovirus. Arrows designate site of cleavage and protease involved. (Reprinted from De Jesus NH. 2007. Epidemics to eradication: the modern history of poliovirus. 4:70, Open access article.)

Citation: Romero J. 2017. Enteroviruses, p 1113-1142. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Cytopathic effect of poliovirus type 1 infection of tissue culture cells : Uninfected Rhesus monkey kidney cells. Poliovirus-infected Rhesus monkey kidney cells 24 hours after infection. Uninfected HEp-2 cells. Poliovirus-infected HEp-2 cells 24 hours after infection. (Reprinted from reference with permission.)

Citation: Romero J. 2017. Enteroviruses, p 1113-1142. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

The natural history of enteroviral aseptic meningitis. Comp. Fix., complement fixation. (Reprinted from reference with permission.)

Citation: Romero J. 2017. Enteroviruses, p 1113-1142. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5
FIGURE 5

Newborn with overwhelming sepsis due to echovirus 11. Note typical enteroviral exanthem. This child's illness began within the first week of life and ended with her death due to hepatic failure at approximately 1 month of age.

Citation: Romero J. 2017. Enteroviruses, p 1113-1142. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 6
FIGURE 6

Herpangina due to Coxsackie A viruses. Small, discrete vesicles surrounded by erythema are seen on the palate, uvula, and elsewhere in the posterior oropharynx.

Citation: Romero J. 2017. Enteroviruses, p 1113-1142. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 7
FIGURE 7

Characteristic lesions of enteroviral hand-foot-mouth disease involving the dorsum of the hand and fingers

Citation: Romero J. 2017. Enteroviruses, p 1113-1142. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819439.ch46
1. Pallanch MA, Oberste MS, Whitton JL,. 2013. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p 490530. In Knipe DM, Howley PM. (ed), Field's Virology, 6th ed. Lippincott, Williams & Wilkins, Philadelphia.
2. Racaniello VR,. 2013. Picornaviridae: the viruses and their replication, p 453489. In Knipe DM, Howley PM (ed), Field's Virology, 6th ed. Lippincott, Williams & Wilkins, Philadelphia.
3. Knowles NJ, Hovi T, Hyypiä T, King AMQ, Lemon SM, Lindberg AM, Pallansch MA, Palmenberg AC, Simmonds P, Skern T, Stanway G, Yamashita T, Zell R,. 2012. Family Picornaviridae, p 855880. In King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (ed), Virus Taxonomy. Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier/Academic Press, London, UK.
4. The Pirbright Institute. UK. Picornavirus.com. Enterovirus. http://www.picornaviridae.com/enterovirus/enterovirus.htm. Accessed June 14, 2015.
5. Landsteiner K, Popper E. 1909. Uebertragung der Poliomyelitis acuta auf Affen. Ztschr Immunitatsforsch 2:377390.
6. Dalldorf G, Sickles GM. 1948. An unidentified, filtrable agent isolated from the feces of children with paralysis. Science 108:6162.[PubMed]
7. Melnick JL, Shaw EW, Curnen EC. 1949. A virus isolated from patients diagnosed as non-paralytic poliomyelitis or aseptic meningitis. Proc Soc Exp Biol Med 71:344349.[PubMed]
8. Committee on the ECHO viruses. 1955. Enteric cytopathogenic human orphan (ECHO) viruses. Science 122:11871188.
9. Rosen L, Melnick JL, Schmidt J, Wenner HA. 1970. Subclassification of enteroviruses and ECHO virus type 34. Brief report. Arch Gesamte Virusforsch 30:8992.[PubMed]
10. Timbury MC. 1963. Antigenic variation in amnion cells after growth in tissue culture in relation to the inhibition of enteroviruses by anticellular serum. Virology 19:501508.[PubMed]
11. Hyypiä T, Horsnell C, Maaronen M, Khan M, Kalkkinen N, Auvinen P, Kinnunen L, Stanway G. 1992. A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci USA 89:88478851.
12. The Pirbright Institute. UK.Picornavirus.com. http://www.picornaviridae.com/parechovirus/parechovirus.htm. Accessed June 14, 2015.
13. Oberste MS, Maher K, Kilpatrick DR, Pallansch MA. 1999. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 73:19411948.
14. Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA. 1999. Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 37:12881293.
15. Burns CC, Diop OM, Sutter RW, Kew OM. 2014. Vaccine-derived polioviruses. J Infect Dis 210(Suppl 1):S283S293.[PubMed]
16. Diop OM, Burns CC, Sutter RW, Wassilak SG, Kew OM Centers for Disease Control and Prevention (CDC). 2015. Update on Vaccine-Derived Polioviruses—Worldwide, January 2014-March 2015. MMWR Morb Mortal Wkly Rep 64:640646.[PubMed]
17. Melnick JL,. 1989. Enteroviruses, p 191263. In Evans AS (ed), Viral Infections of Humans, Epidemiology and Control, 3rd ed. Plenum, New York, NY.
18. Hogle JM, Chow M, Filman DJ. 1985. Three-dimensional structure of poliovirus at 2.9A resolution. Science 229:13581365.
19. Minor PD. 1990. Antigenic structure of picornaviruses. Curr Top Microbiol Immunol 161:121154.[PubMed]
20. Hendry E, Hatanaka H, Fry E, Smyth M, Tate J, Stanway G, Santti J, Maaronen M, Hyypiä T, Stuart D. 1999. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure 7:15271538.
21. Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossmann MG. 1995. The structure of coxsackievirus B3 at 3.5 A resolution. Structure 3:653667.
22. Romero JR. 1999. Reverse-transcription-polymerase chain reaction detection of the enteroviruses: overview and clinical utility in pediatric enteroviral infections. Arch Pathol Lab Med 123:11611169.[PubMed]
23. Stellrecht KA, Lamson DM, Romero JR,. 2011. Enteroviruses and Parechoviruses, p 13881399. In Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (ed), Manual of Clinical Microbiology, 10th ed. ASM Press, Washington, DC.
24. Andino R, Rieckhof GE, Achacoso PL, Baltimore D. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J 12:35873598.[PubMed]
25. Pelletier J, Sonenberg N. 1988. Internal initiation of translation of eukaryotic MRNA directed by a sequence derived from poliovirus RNA. Nature 334:320325.
26. Trono D, Pelletier J, Sonenberg N, Baltimore D. 1988. Translation in mammalian cells of a gene linked to the poliovirus 5′ noncoding region. Science 241:445448.[PubMed]
27. Martínez-Salas E, Francisco-Velilla R, Fernandez-Chamorro J, Lozano G, Diaz-Toledano R. 2015. Picornavirus IRES elements: RNA structure and host protein interactions. Virus Res 206:6273.[PubMed]
28. Minor PD. 1992. The molecular biology of polio vaccines. J Gen Virol 73:30653077.[PubMed]
29. Dunn JJ, Bradrick SS, Chapman NM, Tracy SM, Romero JR. 2003. The stem loop II within the 5′ nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model. J Infect Dis 187:15521561.[PubMed]
30. Minor PD, Ferguson M, Evans DM, Almond JW, Icenogle JP. 1986. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67:12831291.
31. Reimann BY, Zell R, Kandolf R. 1991. Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera. J Virol 65:34753480.[PubMed]
32. Belnap DM, Filman DJ, Trus BL, Cheng N, Booy FP, Conway JF, Curry S, Hiremath CN, Tsang SK, Steven AC, Hogle JM. 2000. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J Virol 74:13421354.
33. Jurgens CK, Barton DJ, Sharma N, Morasco BJ, Ogram SA, Flanegan JB. 2006. 2Apro is a multifunctional protein that regulates the stability, translation and replication of poliovirus RNA. Virology 345:346357.[PubMed]
34. Mendelsohn CL, Wimmer E, Racaniello VR. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell 56:855865.
35. Coyne CB, Bergelson JM. 2006. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124:119131.[PubMed]
36. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:13201323.
37. Newcombe NG, Beagley LG, Christiansen D, Loveland BE, Johansson ES, Beagley KW, Barry RD, Shafren DR. 2004. Novel role for decay-accelerating factor in coxsackievirus A21-mediated cell infectivity. J Virol 78:1267712682.
38. Xiao C, Bator CM, Bowman VD, Rieder E, He Y, Hébert B, Bella J, Baker TS, Wimmer E, Johansson ES, He Y, Bella J, Kuhn RJ, Rossmann MG. 2001. Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1. J Virol 75:24442451.
39. Hughes PJ, Horsnell C, Hyypiä T, Stanway G. 1995. The coxsackievirus A9 RGD motif is not essential for virus viability. J Virol 69:80358040.
40. Roivainen M, Hyypiä T, Piirainen L, Kalkkinen N, Stanway G, Hovi T. 1991. RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol 65:47354740.
41. Yamayoshi S, Ohka S, Fujii K, Koike S. 2013. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol 87:33353347.[PubMed]
42. Yamayoshi S, Fujii K, Koike S. 2014. Receptors for enterovirus 71. Emerg Microbes Infect 3:e53e60.[PubMed]
43. Bubeck D, Filman DJ, Cheng N, Steven AC, Hogle JM, Belnap DM. 2005. The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes. J Virol 79:77457755.
44. Chase AJ, Semler BL. 2012. Viral subversion of host functions for picornavirus translation and RNA replication. Future Virol 7:179191.[PubMed]
45. Paul AV, Wimmer E. 2015. Initiation of protein-primed picornavirus RNA synthesis. Virus Res 206:1226.[PubMed]
46. Jiang P, Liu Y, Ma HC, Paul AV, Wimmer E. 2014. Picornavirus morphogenesis. Microbiol Mol Biol Rev 78:418437.[PubMed]
47. Hsiung GO,. 1973. Enteroviruses, p 5467. In Hsiung GD (ed), Diagnostic Virology. Yale University Press, New Haven.
48. Schlegel A, Kirkegaard K,. 1995. Cell biology of enterovirus infection. p 135154. In Rotbart HA (ed), Human Enterovirus Infection. ASM Press, Washington, DC.
49. Assaad F, Cockburn WC. 1972. Four-year study of WHO virus reports on enteroviruses other than poliovirus. Bull World Health Organ 46:329336.[PubMed]
50. Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA Centers for Disease Control and Prevention (CDC). 2006. Enterovirus surveillance—United States, 1970–2005. MMWR Surveill Summ 55:120.[PubMed]
51. Grist NR, Bell EJ, Assaad F. 1978. Enteroviruses in human disease. Prog Med Virol 24:114157.[PubMed]
52. Hagan JE, Wassilak SG, Craig AS, Tangermann RH, Diop OM, Burns CC, Quddus A Centers for Disease Control and Prevention (CDC). 2015. Progress toward polio eradication—worldwide, 2014–2015. MMWR Morb Mortal Wkly Rep 64:527531.[PubMed]
53. World Health Organization. Poliovirus this week as of 15 July 2015. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx. Accessed July 20, 2015.
54. Moses EB, Dean AG, Hatch MH, Barron AL. 1977. An outbreak of aseptic meningitis in the area of Fort Smith, Arkansas, 1975, due to echovirus type 4. J Ark Med Soc 74:121125.
55. Chambon M, Archimbaud C, Bailly JL, Henquell C, Regagnon C, Charbonné F, Peigue-Lafeuille H. 2001. Circulation of enteroviruses and persistence of meningitis cases in the winter of 1999–2000. J Med Virol 65:340347.[PubMed]
56. Huang QS, Carr JM, Nix WA, Oberste MS, Kilpatrick DR, Pallansch MA, Croxson MC, Lindeman JA, Baker MG, Grimwood K. 2003. An echovirus type 33 winter outbreak in New Zealand. Clin Infect Dis 37:650657.[PubMed]
57. Strikas RA, Anderson LJ, Parker RA. 1986. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970–1983. J Infect Dis 153:346351.
58. Bendinelli M, Ruschi A. 1969. Isolation of human enterovirus from mussels. Appl Microbiol 18:531532.[PubMed]
59. Kelly S, Winkelstein W Jr, Winsser J. 1957. Poliomyelitis and other enteric viruses in sewage. Am J Public Health Nations Health 47:7277.
60. Mitchell JR, Presnell MW, Akin EW, Cummins JM, Liu OC. 1966. Accumulation and elimination of poliovirus by the eastern oyster. Am J Epidemiol 84:4050.
61. Sabin AB, Ward R. 1941. Flies as carriers of poliomyelitis virus in urban epidemics. Science 94:590591.[PubMed]
62. Ward R, Melnick JL, Horstmann DM. 1945. Poliomyelitis virus in fly-contaminated food collected at an epidemic. Science 101:491493.
63. Hawley HB, Morin DP, Geraghty ME, Tomkow J, Phillips CA. 1973. Coxsackievirus B epidemic at a Boy's Summer Camp. Isolation of virus from swimming water. JAMA 226:3336.
64. McLaughlin JB, Gessner BD, Lynn TV, Funk EA, Middaugh JP. 2004. Association of regulatory issues with an echovirus 18 meningitis outbreak at a children's summer camp in Alaska. Pediatr Infect Dis J 23:875877.
65. Begier EM, Oberste MS, Landry ML, Brennan T, Mlynarski D, Mshar PA, Frenette K, Rabatsky-Ehr T, Purviance K, Nepaul A, Nix WA, Pallansch MA, Ferguson D, Cartter ML, Hadler JL. 2008. An outbreak of concurrent echovirus 30 and coxsackievirus A1 infections associated with sea swimming among a group of travelers to Mexico. Clin Infect Dis 47:616623.[PubMed]
66. Abzug MJ. 2004. Presentation, diagnosis, and management of enterovirus infections in neonates. Paediatr Drugs 6:110.[PubMed]
67. Maus MV, Posencheg MA, Geddes K, Elkan M, Peñaranda S, Oberste MS, Hodinka RL. 2008. Detection of echovirus 18 in human breast milk. J Clin Microbiol 46:11371140.[PubMed]
68. Abbott IJ, Papadakis G, Kaye M, Opdam H, Hutton H, Angus PW, Johnson PD, Kanellis J, Westall G, Druce J, Catton M. 2015. Laboratory identification of donor-derived coxsackievirus b3 transmission. Am J Transplant 15:555559.[PubMed]
69. Centers for Disease Control and Prevention (CDC). 2005. Poliovirus infections in four unvaccinated children—Minnesota, August-October 2005. MMWR Morb Mortal Wkly Rep 54:10531055.[PubMed]
70. Centers for Disease Control and Prevention (CDC). 2006. Imported vaccine-associated paralytic poliomyelitis—United States, 2005. MMWR Morb Mortal Wkly Rep 55:9799.[PubMed]
71. Centers for Disease Control and Prevention (CDC). 2001. Apparent global interruption of wild poliovirus type 2 transmission. MMWR Morb Mortal Wkly Rep 50:222224.[PubMed]
72. Kew OM, Cochi SL, Jafari HS, Wassilak SGF, Mast EE, Diop OM, Tangermann RH, Armstrong GL Centers for Disease Control and Prevention (CDC). 2014. Possible eradication of wild poliovirus type 3—worldwide, 2012. MMWR Morb Mortal Wkly Rep 63:10311033.[PubMed]
73. Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, André J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van Der Avoort H,, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C. 2002. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356359.
74. World Health Organization. Circulating Vaccine-derived Polio Cases, 2000–2015. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek/Circulatingvaccinederivedpoliovirus.aspx Accessed June 21, 2015.
75. Antona D, Lévêque N, Chomel JJ, Dubrou S, Lévy-Bruhl D, Lina B. 2007. Surveillance of enteroviruses in France, 2000–2004. Eur J Clin Microbiol Infect Dis 26:403412.
76. Kogon A, Spigland I, Frothingham TE, Elveback L, Williams C, Hall CE, Fox JP. 1969. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in coxsackie and echovirus infections. Am J Epidemiol 89:5161.
77. Trallero G, Casas I, Tenorio A, Echevarria JE, Castellanos A, Lozano A, Breña PP. 2000. Enteroviruses in Spain: virological and epidemiological studies over 10 years (1988–97). Epidemiol Infect 124:497506.
78. Tseng FC, Huang HC, Chi CY, Lin TL, Liu CC, Jian JW, Hsu LC, Wu HS, Yang JY, Chang YW, Wang HC, Hsu YW, Su IJ, Wang JR CDC-Taiwan Virology Reference Laboratories and Sentinel Physician Network. 2007. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. J Med Virol 79:18501860.[PubMed]
79. Kadambari S, Bukasa A, Okike IO, Pebody R, Brown D, Gallimore C, Xerry J, Sharland M, Ladhani SN. 2014. Enterovirus infections in England and Wales, 2000–2011: the impact of increased molecular diagnostics. Clin Microbiol Infect 20:12891296.[PubMed]
80. Harvala H, Calvert J, Van Nguyen D, Clasper L, Gadsby N, Molyneaux P, Templeton K, McWilliams Leitch C, Simmonds P. 2014. Comparison of diagnostic clinical samples and environmental sampling for enterovirus and parechovirus surveillance in Scotland, 2010 to 2012. Euro Surveill 19:20772.[PubMed]
81. Roth B, Enders M, Arents A, Pfitzner A, Terletskaia-Ladwig E. 2007. Epidemiologic aspects and laboratory features of enterovirus infections in Western Germany, 2000–2005. J Med Virol 79:956962.[PubMed]
82. Centers for Disease Control and Prevention (CDC). 2010. Nonpolio enterovirus and human parechovirus surveillance—United States, 2006–2008. MMWR Morb Mortal Wkly Rep 59:15771580.[PubMed]
83. Fox JP, Hall CE, Cooney MK, Luce RE, Kronmal RA. 1972. The Seattle Virus Watch II. Objectives, study population and its observation, data processing, and summary of illnesses. Am J Epidemiol 98:270285.
84. Rantakallio P, Leskinen M, von Wendt L. 1986. Incidence and prognosis of central nervous system infections in a birth cohort of 12,000 children. Scand J Infect Dis 18:287294.
85. Kadambari S, Okike I, Ribeiro S, Ramsay ME, Heath PT, Sharland M, Ladhani SN. 2014. Seven-fold increase in viral meningo-encephalitis reports in England and Wales during 2004–2013. J Infect 69:326332.[PubMed]
86. Michos AG, Syriopoulou VP, Hadjichristodoulou C, Daikos GL, Lagona E, Douridas P, Mostrou G, Theodoridou M. 2007. Aseptic meningitis in children: analysis of 506 cases. PLoS One 2:e674.[PubMed]
87. Berlin LE, Rorabaugh ML, Heldrich F, Roberts K, Doran T, Modlin JF, Wang DM, Zhao GC, Zhuang SM, Zhang YC. 1993. Aseptic meningitis in infants <2 years of age: diagnosis and etiology. J Infect Dis 168:888892.
88. March B, Eastwood K, Wright IM, Tilbrook L, Durrheim DN. 2014. Epidemiology of enteroviral meningoencephalitis in neonates and young infants. J Paediatr Child Health 50:216220.[PubMed]
89. Wang DM, Zhao GC, Zhuang SM, Zhang YC. 1993. An epidemic of encephalitis and meningoencephalitis in children caused by echovirus type 30 in Shanghai. Chin Med J 106:767769.
90. Ray CG, McCollough RH, Doto IL, Todd JC, Glezen WP, Chin TD. 1966. Echo 4 illness: epidemiological, clinical and laboratory studies of an outbreak in a rural community. Am J Epidemiol 84:253267.
91. Yamashita K, Miyamura K, Yamadera S, Kato N, Akatsuka M, Inouye S, Yamazaki S. 1992. Enteroviral aseptic meningitis in Japan, 1981–1991. Jpn J Med Sci Biol 45:151161.
92. Carrol ED, Beadsworth MB, Jenkins N, Ratcliffe L, Ashton I, Crowley B, Nye FJ, Beeching NJ. 2006. Clinical and diagnostic findings of an echovirus meningitis outbreak in the northwest of England. Postgrad Med J 82:6064.
93. Kinnunen E, Hovi T, Stenvik M, Hellström O, Porras J, Kleemola M, Kantanen ML. 1987. Localized outbreak of enteroviral meningitis in adults. Acta Neurol Scand 74:346351.
94. Armed Forces Health Surveillance Center (AFHSC). 2012. Viral meningitis, active and reserve components, U.S. Armed Forces, 2002–2011. MSMR 19:26.[PubMed]
95. Alsop J, Flewett TH, Foster JR. 1960. “Hand-foot-and-mouth disease” in Birmingham in 1959. BMJ 2:17081711.[PubMed]
96. Zahorsky J. Herpangina (A specific disease). 1924. Arch Pediatr 41:181184.
97. Paul JR, Hortstmann DM. 1955. A survey of poliomyelitis virus antibodies in French Morocco. Am J Trop Med Hyg 4:512524.
98. Weinstein L, Shelokov A, Seltser R, Winchell GD. 1952. A comparison of the clinical features of poliomyelitis in adults and children. N Engl J Med 246:296.
99. Nathanson N, Martin JR. 1979. The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am J Epidemiol 110:672692.[PubMed]
100. Kaplan MH, Klein SW, McPhee J, Harper RG. 1983. Group B coxsackievirus infections in infants younger than three months of age: A serious childhood illness. Rev Infect Dis 5:10191032.
101. Modlin JF. 1986. Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev Infect Dis 8:918926.[PubMed]
102. Abzug MJ, Cloud G, Bradley J, Sánchez PJ, Romero J, Powell D, Lepow M, Mani C, Capparelli EV, Blount S, Lakeman F, Whitley RJ, Kimberlin DW National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 2003. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 22:335341.[PubMed]
103. Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ. 2006. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother 50:24092414.
104. Martino TA, Liu P, Petric M, Sole MJ,. 1995. Enteroviral myocarditis and dilated cardiomyopathy: A review of clinical and experimental studies, p 291351. In Rotbart HA (ed), Human Enterovirus Infections. ASM Press, Washington, DC.
105. Russell WR. 1947. Poliomyelitis; the pre-paralytic stage, and the effect of physical activity on the severity of paralysis. BMJ 2:10231028.[PubMed]
106. Russell WR. 1949. Paralytic poliomyelitis; the early symptoms and the effect of physical activity on the course of the disease. BMJ 1:465471.[PubMed]
107. Horstmann DM. 1950. Acute poliomyelitis relation of physical activity at the time of onset to the course of the disease. J Am Med Assoc 142:236241.
108. Gatmaitan BG, Chason JL, Lerner AM. 1970. Augmentation of the virulence of murine coxsackievirus B-3 myocardiopathy by exercise. J Exp Med 131:11211136.
109. Khetsuriani N, Lamonte A, Oberste MS, Pallansch M. 2006. Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983–2003. Pediatr Infect Dis J 25:889893.
110. Morens DM, Pallansch MA,. 1995. Epidemiology, p 323. In Rotbart HA (ed), Human Enterovirus Infections. ASM Press, Washington, DC.
111. Gromeier M, Nomoto A,. 2002. Determinants of poliovirus pathogenesis, p 367379. In Semler BL, Wimmer E (ed), Molecular biology of picornaviruses. ASM Press, Washington, DC.
112. Racaniello VR. 2006. One hundred years of poliovirus pathogenesis. Virology 344:916.[PubMed]
113. Bodian D. 1952. Pathogenesis of poliomyelitis. Am J Public Health Nations Health 42:13881402.[PubMed]
114. Bodian D. 1955. Emerging concept of poliomyelitis infection. Science 122:105108.[PubMed]
115. Sabin AB, Ward R. 1941. The natural history of human poliomyelitis: I. Distribution of virus in nervous and non-nervous tissues. J Exp Med 73:771793.[PubMed]
116. Iwasaki A, Welker R, Mueller S, Linehan M, Nomoto A, Wimmer E. 2002. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. J Infect Dis 186:585592.
117. Siciński P, Rowiński J, Warchoł JB, Jarzabek Z, Gut W, Szczygieł B, Bielecki K, Koch G. 1990. Poliovirus type 1 enters the human host through intestinal M cells. Gastroenterology 98:5658.
118. Yang WX, Terasaki T, Shiroki K, Ohka S, Aoki J, Tanabe S, Nomura T, Terada E, Sugiyama Y, Nomoto A. 1997. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 229:421428.
119. Hurst EW. 1936. Newer knowledge of virus diseases of nervous system: a review and an interpretation. Brain 59:134.
120. Nathanson N, Bodian D. 1961. Experimental poliomyelitis following intramuscular virus injection. I. The effect of neural block on a neurotropic and a pantropic strain. Bull Johns Hopkins Hosp 108:308319.[PubMed]
121. Ohka S, Yang WX, Terad a E, Iwasaki K, Nomoto A. 1998. Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology 250:6775.
122. Nathanson N, Langmuir A. 1963. The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955: III. Comparison of the clinical character of vaccinated and contact cases occurring after use of high rate lots of Cutter vaccine. Am J Epidem 78:6181.
123. Strebel PM, Ion-Nedelcu N, Baughman AL, Sutter RW, Cochi SL. 1995. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine—a risk factor for vaccine-associated paralytic poliomyelitis. N Engl J Med 332:500506.
124. Sutter RW, Patriarca PA, Suleiman AJ, Brogan S, Malankar PG, Cochi SL, Al-Ghassani AA, el-Bualy MS. 1992. Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. J Infect Dis 165:444449.
125. Gromeier M, Wimmer E. 1998. Mechanism of injury-provoked poliomyelitis. J Virol 72:50565060.[PubMed]
126. Ohka S, Nihei C, Yamazaki M, Nomoto A. 2012. Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway. Front Microbiol 3:147.[PubMed]
127. Leon-Monzo n ME, Illa I, Dalakas MC. 1995. Expression of poliovirus receptor in human spinal cord and muscle. Ann N Y Acad Sci 753:4857.
128. Freistadt MS, Kaplan G, Racaniello VR. 1990. Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol 10:57005706.
129. Ren R, Racaniello VR. 1992. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol 66:296304.[PubMed]
130. Bradrick SS, Lieben EA, Carden BM, Romero JR. 2001. A predicted secondary structural domain within the internal ribosome entry site of echovirus 12 mediates a cell-type-specific block to viral replication. J Virol 75:64726481.[PubMed]
131. Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, Yoneyama M, Fujita T, Taya C, Yonekawa H, Koike S. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol 79:44604469.
132. Yoshikawa T, Iwasaki T, Ida-Hosonuma M, Yoneyama M, Fujita T, Horie H, Miyazawa M, Abe S, Simizu B, Koike S. 2006. Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture. J Virol 80:43134325.
133. de Ory F, Avellón A, Echevarría JE, Sánchez-Seco MP, Trallero G, Cabrerizo M, Casas I, Pozo F, Fedele G, Vicente D, Pena MJ, Moreno A, Niubo J, Rabella N, Rubio G, Pérez-Ruiz M, Rodríguez-Iglesias M, Gimeno C, Eiros JM, Melón S, Blasco M, López-Miragaya I, Varela E, Martinez-Sapiña A, Rodríguez G, Marcos , Gegúndez MI, Cilla G, Gabilondo I, Navarro JM, Torres J, Aznar C, Castellanos A, Guisasola ME, Negredo AI, Tenorio A, Vázquez-Morón S. 2013. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol 85:554562.[PubMed]
134. McKinney RE Jr, Katz SL, Wilfert CM. 1987. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 9:334356.
135. Minor PD, John A, Ferguson M, Icenogle JP. 1986. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol 67:693706.
136. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU. 1999. Enteroviral protease 2A cleaves dystrophin: evidence of a cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320326.
137. Dunn JJ, Chapman NM, Tracy S, Romero JR. 2000. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. J Virol 74:47874794.[PubMed]
138. Weinzierl AO, Szalay G, Wolburg H, Sauter M, Rammensee HG, Kandolf R, Stevanović S, Klingel K. 2008. Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J Virol 82:81498160.[PubMed]
139. Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JL, Varela J, David RM, Banks L, Huang CH, Li H, Schultheiss HP, Towbin JA, Vallejo JG, Bowles NE. 2010. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem 285:2320823223.[PubMed]
140. Satoh M, Akatsu T, Ishikawa Y, Minami Y, Takahashi Y, Nakamura M. 2007. Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy. Am Heart J 154:581588.[PubMed]
141. Bodian D. 1949. Histopathologic basis of clinical findings in poliomyelitis. Am J Med 6:563578.[PubMed]
142. Cree BC, Bernardini GL, Hays AP, Lowe G. 2003. A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol 60:107712.
143. Price RA, Garcia JH, Rightsel WA. 1970. Choriomeningitis and myocarditis in an adolescent with isolation of Coxsackie B-5 virus. Am J Clin Pathol 53:825831.
144. Sutinen S, Kalliomäki JL, Pohjonen R, Vastamäki R. 1971. Fatal generalized coxsackie B3 virus infection in an adolescent with successful isolation of the virus from pericardial fluid. Ann Clin Res 3:241246.
145. Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, Lim WL,, Ong BB, Paul G, AbuBakar S, Lambert M. 1998. Fatal enterovirus 71 encephalomyelitis. J Pediatr 133:795798.[PubMed]
146. Kreuter JD, Barnes A, McCarthy JE, Schwartzman JD, Oberste MS, Rhodes CH, Modlin JF, Wright PF. 2011. A fatal central nervous system enterovirus 68 infection. Arch Pathol Lab Med 135:793796.[PubMed]
147. Muehlenbachs A, Bhatnagar J, Zaki SR. 2015. Tissue tropism, pathology and pathogenesis of enterovirus infection. J Pathol 235:217228.[PubMed]
148. Aretz HT. 1987. Myocarditis: the Dallas criteria. Hum Pathol 18:619624.[PubMed]
149. Ventura KC, Hawkins H, Smith MB, Walker DH. 2001. Fatal neonatal echovirus 6 infection: autopsy case report and review of the literature. Mod Pathol 14:8590.[PubMed]
150. Miller GD, Tindall JP. 1968. Hand-foot-and-mouth disease. JAMA 203:827830.[PubMed]
151. Horstmann DM. 1949. Clinical aspects of acute poliomyelitis. Am J Med 6:592605.[PubMed]
152. Auld PA, Kevy SV, Eley RC. 1960. Poliomyelitis in children: experience with 956 cases in the 1955 Massachusetts epidemic. N Engl J Med 263:10931100.
153. Lucchesi PF. 1934. Poliomyelitis: a study of 410 patients at the Philadelphia Hospital for Contagious Diseases. Am J Med Sci 4:515523.
154. Watkins A. 1949. Progressive disabilities in poliomyelitis, p 142143. In Poliomyelitis: papers and discussions presented at the first international poliomyelitis conference. J.B. Lippincott, Philadelphia.
155. Gonzalez H, Olsson T, Borg K. 2010. Management of postpolio syndrome. Lancet Neurol 9:634642.[PubMed]
156. Dalakas MC, Bartfield H, Kurland T. 1995. The post-polio syndrome: advances in the pathogenesis and treatment. Ann N Y Acad Sci 753:1412.[PubMed]
157. Bickerstaffe A, van Dijk JP, Beelen A, Zwarts MJ, Nollet F. 2014. Loss of motor unit size and quadriceps strength over 10 years in post-polio syndrome. Clin Neurophysiol 125:12551260.[PubMed]
158. Abzug MJ, Levin MJ, Rotbart HA. 1993. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J 12:820824.[PubMed]
159. Horstmann DM, Yamada N. 1968. Enterovirus infections of the central nervous system. Res Publ Assoc Res Nerv Ment Dis 44:236253.[PubMed]
160. Rorabaugh ML, Berlin LE, Heldrich F, Roberts K, Rosenberg LA, Doran T, Modlin JF. 1993. Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics 92:206211.
161. Peigue-Lafeuille H, Croquez N, Laurichesse H, Clavelou P, Aumaître O, Schmidt J, Maillet-Vioud M, Henquell C, Archimbaud C, Bailly JL, Chambon M. 2002. Enterovirus meningitis in adults in 1999–2000 and evaluation of clinical management. J Med Virol 67:4753.
162. Rotbart HA, Brennan PJ, Fife KH, Romero JR, Griffin JA, McKinlay MA, Hayden FG. 1998. Enterovirus meningitis in adults. Clin Infect Dis 27:896898.
163. Singer JI, Maur PR, Riley JP, Smith PB. 1980. Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis. J Pediatr 96:559563.
164. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med 341:929935.
165. Solomon P, Weinstein L, Chang TW, Artenstein MS, Ambrose CT. 1959. Epidemiologic, clinical and laboratory features of an epidemic of type 9 Echo virus meningitis. J Pediatr 55:609619.